growth/size/body
• progressive increase in body weight from 6 to 12 weeks of age, however a 15-20% reduction in body weight is seen compared to single Leprdb homozygotes
|
• increase in liver weight in both males and females compared to either single heterozygous mice, however liver weight in males is reduced compared to single Leprdb homozygotes
|
adipose tissue
• increase in adipose tissue weight compared to either single heterozygous mice, however visceral adipose tissue weight is reduced compared to single Leprdb homozygotes
|
homeostasis/metabolism
• plasma levels of SHBG in obese males do not increase from week 4 to week 6 and remain lower at 8 weeks of age unlike in controls and this is due to altered hepatic HNF-4alpha and PPAR-gamma mRNA and protein levels
|
• obese mice develop hyperglycemia after 6 weeks of age to a similar extent as single Leprdb homozygotes
|
• total testosterone plasma levels are reduced in obese males
|
• higher plasma insulin levels in obese males and females comparable to single Leprdb homozygotes
|
• higher plasma leptin levels in obese males and females comparable to single Leprdb homozygotes
|
• obese males and females exhibit higher plasma cholesterol levels comparable to single Leprdb homozygotes
|
• higher plasma nonsterified fatty acids level in obese males and females comparable to single Leprdb homozygotes
|
• obese males and females exhibit higher plasma triglycerides with levels comparable to single Leprdb homozygotes
|
liver/biliary system
• increase in liver weight in both males and females compared to either single heterozygous mice, however liver weight in males is reduced compared to single Leprdb homozygotes
|
• mice develop fatty liver
|
renal/urinary system
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
obesity | DOID:9970 |
OMIM:601665 |
J:232827 |